TYRP1 mRNA level is stable and MITF-M-independent in drug-naive, vemurafenib- and trametinib-resistant BRAFV600E melanoma cells.
Ontology highlight
ABSTRACT: TYRP1 mRNA is of interest due to its potential non-coding role as a sponge sequestering tumor-suppressive miRs in melanoma. To our knowledge, there is no report on changes in TYRP1 expression in melanomas after development of resistance to targeted therapies. We used patient-derived drug-naïve RASQ61R and BRAFV600E melanoma cell lines. In BRAFV600E melanoma cells, resistance to vemurafenib and trametinib was developed. A time-lapse fluorescence microscope was used to rate proliferation, qRT-PCR and Western blotting were used to assess TYRP1 expression and MITF-M level and activity. A high TYRP1 protein level in RASQ61R cells corresponded with high TYRP1 mRNA level, whereas undetectable TYRP1 protein in BRAFV600E cells was accompanied b
SUBMITTER: Hartman ML
PROVIDER: S-EPMC7248034 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA